A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

Clinical trial NCT04328844 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04328844
Sponsor: iOnctura
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Non-Hodgkin Lymphoma, Adult NSCLC Myelofibrosis Uveal Melanoma

Start date: 2020-02-25
Primary completion: 2023-12-13
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.